(Q41547569)

3 October 2017

title

Programmed cell death protein 1 expression is an independent prognostic factor in gastric cancer after curative resection (English)

1 reference

3 October 2017

Shohei Eto

1

1 reference

3 October 2017

Kozo Yoshikawa

2

1 reference

3 October 2017

Masaaki Nishi

3

1 reference

3 October 2017

Jun Higashijima

4

1 reference

3 October 2017

Takuya Tokunaga

5

1 reference

3 October 2017

Toshihiro Nakao

6

1 reference

3 October 2017

Hideya Kashihara

7

1 reference

3 October 2017

Chie Takasu

8

1 reference

3 October 2017

Takashi Iwata

9

1 reference

3 October 2017

Mitsuo Shimada

10

1 reference

3 October 2017

publication date

26 July 2015

1 reference

3 October 2017

1 reference

3 October 2017

volume

19

1 reference

3 October 2017

issue

2

1 reference

3 October 2017

page(s)

466-471

1 reference

https://scigraph.springernature.com/pub.10.1007/s10120-015-0519-7

3 October 2017

exact match

0 references

cites work

The presence of programmed death 1 (PD-1)-positive tumor-infiltrating lymphocytes is associated with poor prognosis in human breast cancer.

1 reference

12 December 2020

Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death

1 reference

12 December 2020

Human hepatocellular carcinoma-infiltrating CD4⁺CD69⁺Foxp3⁻ regulatory T cell suppresses T cell response via membrane-bound TGF-β1

1 reference

12 December 2020

Differential pattern and prognostic significance of CD4+, FOXP3+ and IL-17+ tumor infiltrating lymphocytes in ductal and lobular breast cancers

1 reference

12 December 2020

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

1 reference

12 December 2020

Escape from immunotherapy: possible mechanisms that influence tumor regression/progression.

1 reference

12 December 2020

Combinatorial PD-1 blockade and CD137 activation has therapeutic efficacy in murine cancer models and synergizes with cisplatin

1 reference

12 December 2020

Oestrogen treatment of experimental autoimmune encephalomyelitis requires 17β-oestradiol-receptor-positive B cells that up-regulate PD-1 on CD4+ Foxp3+ regulatory T cells

1 reference

12 December 2020

Japanese classification of gastric carcinoma: 3rd English edition

1 reference

12 December 2020

High tissue density of FOXP3+ T cells is associated with clinical outcome in prostate cancer

1 reference

12 December 2020

Expression of PD-1 (CD279) and FoxP3 in diffuse large B-cell lymphoma

1 reference

12 December 2020

Regulation of PD‐1, PD‐L1, and PD‐L2 expression during normal and autoimmune responses

1 reference

12 December 2020

The new B7s: playing a pivotal role in tumor immunity

1 reference

12 December 2020

Ipilimumab plus dacarbazine for previously untreated metastatic melanoma

1 reference

12 December 2020

Increased PD-1 expression on CD4+ and CD8+ T cells is involved in immune evasion in gastric cancer

1 reference

12 December 2020

PD-1(+) immune cell infiltration inversely correlates with survival of operable breast cancer patients

1 reference

12 December 2020

Prognostic implications of immunosuppressive protein expression in tumors as well as immune cell infiltration within the tumor microenvironment in gastric cancer.

1 reference

12 December 2020

Escape strategies and reasons for failure in the interaction between tumour cells and the immune system: how can we tilt the balance towards immune-mediated cancer control?

1 reference

12 December 2020

Immunoregulatory molecule B7-H1 (CD274) contributes to skin carcinogenesis

1 reference

12 December 2020

The role of FOXP3 in the development and metastatic spread of breast cancer.

1 reference

12 December 2020

Prognostic significance of programmed cell death 1 (PD-1) or PD-1 ligand 1 (PD-L1) Expression in epithelial-originated cancer: a meta-analysis

1 reference

12 December 2020

Targeting the PD1/PD-L1 axis in melanoma: biological rationale, clinical challenges and opportunities

1 reference

12 December 2020

Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy

1 reference

12 December 2020

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

1 reference

12 December 2020

10.1007/S10120-015-0519-7

Identifiers

DOI

1 reference

3 October 2017

1 reference